Torben Zachmann
About Torben Zachmann
Torben Zachmann serves as the Senior Director of Cell Therapy at Kite Pharma, Inc., a position he has held since 2018. He has extensive experience in the biopharmaceutical industry, having previously held leadership roles at Gilead Sciences and Novartis, among others.
Current Role at Kite Pharma
Torben Zachmann serves as the Senior Director of Cell Therapy at Kite Pharma, Inc. He has held this position since 2018 in Santa Monica, California. In this role, he oversees various aspects of cell therapy development and implementation, contributing to the company's focus on innovative cancer treatments.
Previous Experience at Gilead Sciences
Zachmann worked at Gilead Sciences from 2013 to 2018, where he held two significant roles. He was the Business Unit Director for Hematology and Oncology from 2013 to 2016, followed by a position as Business Unit Director for Liver Diseases from 2016 to 2018. Both roles were based in Foster City, California.
Experience at Novartis
Zachmann's tenure at Novartis spanned from 1998 to 2013, during which he held various positions. He began as a Researcher in 1998, later becoming the Director of Commercial Excellence in 2011 and the Franchise Head for Oncology Region Europe in 2012. His work at Novartis took place in Basel, Switzerland.
Background in Biopharmaceuticals
Before his roles at Gilead and Novartis, Zachmann worked at Amgen from 2002 to 2010 in various capacities, including Executive Biopharmaceutical Sales Representative and Product Manager for Hematology and Oncology. His experience at Amgen provided him with a strong foundation in biopharmaceutical sales and marketing.
Education and Qualifications
Zachmann holds a Master of Business Administration from the Rotterdam School of Management, Erasmus University, where he studied from 2001 to 2003. He also studied Chemical Engineering at the Karlsruhe Institute of Technology from 1992 to 1994. His educational background supports his expertise in both business and scientific aspects of the pharmaceutical industry.